Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Angeion begins European trials of Sentinel 2010:

This article was originally published in Clinica

Executive Summary

Angeion has begun clinical evaluation of its Sentinel 2010 implantable cardioverter defibrillator. The first device was implanted in a patient in the Czech Republic. The 60 cc 2010 series weighs 110 g and stores 5.5 minutes of ECG. It is based on the Sentinel 2000, which is currently in US clinical trials and has been audited for CE marking by TUV Product Services of Munich, Germany.

Topics

UsernamePublicRestriction

Register

MT088147

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel